Bibliographic Info
GuidelineWHO consolidated guidelines on tuberculosis: module 4: treatment and care
Year of Publication2025
Issuing InstitutionWorld Health Organization
Recommendation
Status
Updated
Recommended against
Conditional
Certainty of evidence
Very low
WHO suggests against using 9-month DCLLfxZ or DCMZ regimen compared with currently recommended longer (>18 months) regimens in patients with fluoroquinolone-susceptible MDR/ RR-TB.